Skip to main content

Duloxetine News

FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain

Indications include osteoarthritis, chronic lower back pain ROCKVILLE, Md., Nov. 4, 2010--The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic...

FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder

INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ – The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the maintenance treatment of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Back Pain, Chronic Pain, Chronic Fatigue Syndrome (CFS), Anxiety, Bipolar Disorder, Depression, Fibromyalgia, Peripheral Neuropathy, Dysthymia, view more... Hot Flashes, Pain, Osteoarthritis, Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Neuropathy, Diabetic Nerve Damage, Urinary Incontinence

Related drug support groups

Cymbalta

Duloxetine patient information at Drugs.com